107 related articles for article (PubMed ID: 36229929)
21. Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model.
Niedergethmann M; Alves F; Neff JK; Heidrich B; Aramin N; Li L; Pilarsky C; Grützmann R; Allgayer H; Post S; Gretz N
Br J Cancer; 2007 Nov; 97(10):1432-40. PubMed ID: 17940512
[TBL] [Abstract][Full Text] [Related]
22. Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer.
Lukosiute-Urboniene A; Jasukaitiene A; Silkuniene G; Barauskas V; Gulbinas A; Dambrauskas Z
World J Gastroenterol; 2019 Jan; 25(2):205-219. PubMed ID: 30670910
[TBL] [Abstract][Full Text] [Related]
23. LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of Pancreatic Cancer.
Zheng B; Qu J; Ohuchida K; Feng H; Chong SJF; Yan Z; Piao Y; Liu P; Sheng N; Eguchi D; Ohtsuka T; Mizumoto K; Liu Z; Pervaiz S; Gong P; Nakamura M
Theranostics; 2020; 10(22):10274-10289. PubMed ID: 32929348
[No Abstract] [Full Text] [Related]
24. Oligonucleotide microarray identifies genes differentially expressed during tumorigenesis of DMBA-induced pancreatic cancer in rats.
Guo JC; Li J; Yang YC; Zhou L; Zhang TP; Zhao YP
PLoS One; 2013; 8(12):e82910. PubMed ID: 24376604
[TBL] [Abstract][Full Text] [Related]
25. Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes.
Shi W; Qiu W; Wang W; Zhou X; Zhong X; Tian G; Deng A
Biosci Trends; 2014 Dec; 8(6):322-6. PubMed ID: 25641178
[TBL] [Abstract][Full Text] [Related]
26. LOX and ACSL5 as potential relapse markers for pancreatic cancer patients.
Ma W; Li T; Wu S; Li J; Wang X; Li H
Cancer Biol Ther; 2019; 20(6):787-798. PubMed ID: 30712446
[TBL] [Abstract][Full Text] [Related]
27. Prognostic analysis of patients with pancreatic head adenocarcinoma less than 2 cm undergoing resection.
Chiang KC; Yeh CN; Lee WC; Jan YY; Hwang TL
World J Gastroenterol; 2009 Sep; 15(34):4305-10. PubMed ID: 19750574
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A.
Hoskins JW; Jia J; Flandez M; Parikh H; Xiao W; Collins I; Emmanuel MA; Ibrahim A; Powell J; Zhang L; Malats N; Bamlet WR; Petersen GM; Real FX; Amundadottir LT
Carcinogenesis; 2014 Dec; 35(12):2670-8. PubMed ID: 25233928
[TBL] [Abstract][Full Text] [Related]
29. RUNX2 and LAMC2: promising pancreatic cancer biomarkers identified by an integrative data mining of pancreatic adenocarcinoma tissues.
Jin G; Ruan Q; Shangguan F; Lan L
Aging (Albany NY); 2021 Oct; 13(19):22963-22984. PubMed ID: 34606473
[TBL] [Abstract][Full Text] [Related]
30. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
32. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic cancer survival analysis defines a signature that predicts outcome.
Raman P; Maddipati R; Lim KH; Tozeren A
PLoS One; 2018; 13(8):e0201751. PubMed ID: 30092011
[TBL] [Abstract][Full Text] [Related]
34. Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer.
Liu B; Fu T; He P; Du C; Xu K
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34143198
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic cancer biomarker detection by two support vector strategies for recursive feature elimination.
Wang Y; Liu K; Ma Q; Tan Y; Du W; Lv Y; Tian Y; Wang H
Biomark Med; 2019 Feb; 13(2):105-121. PubMed ID: 30767554
[TBL] [Abstract][Full Text] [Related]
36. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
[TBL] [Abstract][Full Text] [Related]
37. [Quantitative analysis and significance of CXCL12 and CXCR4 expression with lymphangiogenesis of pancreatic adenocarcinoma].
Fei LM; Wang CL; Zhao WH; Cui K; Zhang B; Zhou WY; Zhong WX; Li S
Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):783-6. PubMed ID: 19615218
[TBL] [Abstract][Full Text] [Related]
38. Identification of Key Genes Involved in Pancreatic Ductal Adenocarcinoma with Diabetes Mellitus Based on Gene Expression Profiling Analysis.
Zhou W; Wang Y; Gao H; Jia Y; Xu Y; Wan X; Zhang Z; Yu H; Yan S
Pathol Oncol Res; 2021; 27():604730. PubMed ID: 34257566
[TBL] [Abstract][Full Text] [Related]
39. iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma.
Wang WS; Liu XH; Liu LX; Lou WH; Jin DY; Yang PY; Wang XL
J Proteomics; 2013 Oct; 91():453-65. PubMed ID: 23851313
[TBL] [Abstract][Full Text] [Related]
40. Protein deep sequencing applied to biobank samples from patients with pancreatic cancer.
Ansari D; Andersson R; Bauden MP; Andersson B; Connolly JB; Welinder C; Sasor A; Marko-Varga G
J Cancer Res Clin Oncol; 2015 Feb; 141(2):369-80. PubMed ID: 25216700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
